Table 3 MSC-Exos in clinical trials related to tumor therapy
From: Progress of mesenchymal stem cell-derived exosomes in targeted delivery of antitumor drugs
Disease | Study Design | Clinical Trial ID Number | Year and Location | Status |
|---|---|---|---|---|
Pancreatic cancer | Phase I, open-label | NCT03608631 | 2018, United States | Completed |
Colorectal cancer | Phase I, open-label | NCT01294072 | 2011, United States | Completed |
Hepatocellular carcinoma | Phase I, open-label, dose escalation | NCT05375604 | 2022, United States | Unknown |
Lung cancer | Phase II, open-label | NCT01159288 | 2015, France | Completed |